| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 6e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.31 | 0.003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |